Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Verastem, Inc.VSTM · Entity 5242 | Director · President and CEO | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Verastem, Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 652,712 |
Ending reported balance
After 2026-10-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-30 · Grant · Disposed 106,893 · Balance 696,833 F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved. Row 2 · 2026-10-01 · Sale · Disposed 44,121 · Balance 652,712 F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved.
F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (right to buy) · Derivative | 144,137 | Not disclosed Strike: $11.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 13 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,137 Underlying: Common Stock · 144,137 shares Expires 2034-03-11 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 30,708 | Not disclosed Strike: $28.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 12 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,708 shares Expires 2031-01-04 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F13 · derivative.exercise_date: The canceled option was granted on December 15, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 33,962 | Not disclosed Strike: $26.40 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 11 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,962 shares Expires 2030-12-18 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F12 · derivative.exercise_date: The canceled option was granted on December 18, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 12,500 | Not disclosed Strike: $16.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 10 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2029-12-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F11 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 16,666 | Not disclosed Strike: $16.08 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 9 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2029-12-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F10 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and vesting as to 12.5% of the shares underlying the option at the end of each successive three-month period following the first anniversary of grant date until the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 20,832 | Not disclosed Strike: $21.72 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 8 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,832 shares Expires 2029-06-21 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F9 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 6,250 | Not disclosed Strike: $42.12 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 7 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2029-01-03 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F8 · derivative.exercise_date: The canceled option was granted on January 3, 2019 and provided for vesting as to 25% of the shares underlying the option on January 1, 2020 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2023. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 3,750 | Not disclosed Strike: $35.64 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 6 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2028-01-05 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F7 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting based on the achievement of certain performance milestones which were met by June 30, 2018 and by March 31, 2019. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 6,249 | Not disclosed Strike: $35.64 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 5 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,249 shares Expires 2028-01-05 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F6 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting as to 25% of the shares underlying the option on January 1, 2019 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2022. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 8,333 | Not disclosed Strike: $16.44 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 4 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2026-06-13 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F5 · derivative.exercise_date: The canceled option was granted on June 14, 2016 and provided for vesting as to 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in June 2017, and vesting as to the remaining 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in September 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 5,500 | Not disclosed Strike: $22.32 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 3 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2025-12-31 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F4 · derivative.exercise_date: The canceled option was granted on January 1, 2016 and provided for vesting as to 50% of the shares underlying the option on November 9, 2016, and vesting as to the remaining 50% of the shares underlying the option on November 9, 2017. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 11,166 | Not disclosed Strike: $25.56 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,166 shares Expires 2025-11-08 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F3 · derivative.exercise_date: The canceled option was granted on November 9, 2015 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date, and vesting as to the remaining 50% of the shares underlying the option on the second anniversary of the grant date. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 22:12 UTC | Verastem, Inc. VSTM · Entity 5242 | Disposition to issuerStock Option (right to buy) · Derivative | 12,064 | Not disclosed Strike: $110.28 | Not disclosed |
DisclosureSEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,064 shares Expires 2025-01-08 F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date. F2 · derivative.exercise_date: The canceled option was granted on January 8, 2015 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 21:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 183 | $7.73 | $1,414.59 |
DisclosureSEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,916 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 21:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $7.64 | $1,864.16 |
DisclosureSEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,099 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2023 Filed Sep 20, 2023 20:15 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 183 | $9.84 | $1,800.72 |
DisclosureSEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,343 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 18, 2023 Filed Sep 20, 2023 20:15 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 240 | $9.91 | $2,378.40 |
DisclosureSEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,526 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:40 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $10.44 | $0.00 |
DisclosureSEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-08-02 F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of August 2, 2023 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| August 02, 2023 Filed Aug 4, 2023 20:40 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,766 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of August 2, 2023 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:25 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 183 | $10.30 | $1,884.90 |
DisclosureSEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,766 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:25 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 244 | $9.92 | $2,420.48 |
DisclosureSEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,949 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 20, 2023 Filed Mar 20, 2023 20:57 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,339 | $0.43 | $1,005.77 |
DisclosureSEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,351 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 20, 2023 20:57 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 3,138 | $0.40 | $1,255.20 |
DisclosureSEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,690 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 21:06 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 1,680,880 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001104659-23-008593 · tm234891-2_4seq1.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680,880 Underlying: Common Stock · 1,680,880 shares Expires 2033-01-27 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of January 27, 2023 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 21:10 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,954 | $0.37 | $1,092.98 |
DisclosureSEC source: 0001104659-22-128644 · tm2233121-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 463,828 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 21:10 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 15,676 | $0.40 | $6,270.40 |
DisclosureSEC source: 0001104659-22-128644 · tm2233121-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,782 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:07 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,786 | $1.13 | $3,148.18 |
DisclosureSEC source: 0001104659-22-101925 · tm2226273-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,458 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:06 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,701 | $1.14 | $3,079.14 |
DisclosureSEC source: 0001104659-22-073486 · tm2219034-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,244 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 16, 2022 Filed May 17, 2022 20:09 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 4,988 | $1.03 | $5,137.64 |
DisclosureSEC source: 0001104659-22-061939 · tm2215781-3_4seq1.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,945 F2 · shares: - The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| May 14, 2022 Filed May 17, 2022 20:09 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-061939 · tm2215781-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,933 F1 · shares: - Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on June 24, 2021 under the Issuer's 2021 Equity Incentive Plan. Each PRSU represents the right to receive one share of Common Stock. On May 14, 2022 the Compensation Committee of the Issuer's Board of Directors certified that the PRSUs' performance criteria had been satisfied and the PRSUs vested in full. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 20:02 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 2,818 | $1.27 | $3,578.86 |
DisclosureSEC source: 0001104659-22-037009 · tm2210137-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,933 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 23,534 | $2.05 | $48,244.70 |
DisclosureSEC source: 0001104659-22-001447 · tm221611-1_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,751 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:01 UTC | Verastem, Inc. VSTM · Entity 5242 | SaleCommon Stock | 10,994 | $2.27 | $24,956.38 |
DisclosureSEC source: 0001104659-21-152597 · tm2136040-2_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,285 F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 368,500 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · derivative · entry 4 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,500 Underlying: Common Stock · 368,500 shares Expires 2031-12-15 F5 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 15, 2021 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:02 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 181,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · nonDerivative · entry 3 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,279 F4 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of December 15, 2021 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| August 12, 2021 Filed Dec 17, 2021 21:02 UTC | Verastem, Inc. VSTM · Entity 5242 | Tax withholdingCommon Stock | 50,244 | $2.87 | $144,200.28 |
DisclosureSEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,779 F1 · balance_after: The total reflects the disposition of 50,244 shares sold by the Issuer to satisfy statutory withholding requirements and an additional reduction of 46,442 shares previously withheld by the Issuer to satisfy statutory withholding requirements, in each case upon vesting of restricted stock units and a reduction of 128,684 shares transferred to the Paterson 1996 Living Trust. The total also reflects 3,333 shares purchased under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 18:26 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 407,552 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000904454-20-000828 · edgar.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,552 Underlying: Common Stock · 407,552 shares Expires 2030-12-18 F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 18, 2020 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 18, 2020 Filed Dec 22, 2020 18:26 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 135,851 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000828 · edgar.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,816 F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of December 18, 2020 (the "Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 15:58 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 321,679 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-20-000566 · edgar.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,965 F1 · shares: Represents restricted stock units granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of Common Stock. The restricted stock units vest 50% on December 31, 2020 and 50% on August 11, 2021, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 00:59 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-040697 · a4.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,286 F1 · shares: Represents restricted stock units granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan on March 27, 2020. Each restricted stock unit represents the contingent right to receive one share of Common Stock. The restricted stock units vest as to 100% of the shares on December 31, 2021, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on such vesting date. Read SEC document |
| December 13, 2019 Filed Dec 18, 2019 00:39 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001104659-19-073506 · a4.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-12-13 F2 · derivative.exercise_date: The option vests as to 50% of the shares on the first anniversary of Grant Date and as to an additional 12.5% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| December 13, 2019 Filed Dec 18, 2019 00:39 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $1.34 | $0.00 |
DisclosureSEC source: 0001104659-19-073506 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-12-13 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 13, 2019 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| June 21, 2019 Filed Jun 26, 2019 01:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001104659-19-037508 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-06-21 F1 · derivative.exercise_date: The option vests as to 50% of the shares on the first anniversary of the date of grant and as to an additional 12.5% of the shares at the end of each successive three-month period following the first anniversary of the date of grant, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000904454-19-000030 · edgar.xml · derivative · entry 2 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-03 F2 · derivative.exercise_date: The option vests as to: (a) 40% of the shares upon the date on which the closing price per share of the common stock is at least $10.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, (b) 40% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $15.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, and (c) 20% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $20.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 21:52 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $3.51 | $0.00 |
DisclosureSEC source: 0000904454-19-000030 · edgar.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of January 1, 2019 (the "Commencement Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Commencement Date until the fourth anniversary of the Commencement Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 22:58 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 3,000 | $7.00 | $21,000.00 |
DisclosureSEC source: 0000904454-18-000631 · edgar.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,286 Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 22:35 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 1,200 | $7.04 | $8,448.00 |
DisclosureSEC source: 0000904454-18-000611 · edgar.xml · nonDerivative · entry 2 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,286 Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 22:35 UTC | Verastem, Inc. VSTM · Entity 5242 | PurchaseCommon Stock | 800 | $7.01 | $5,608.00 |
DisclosureSEC source: 0000904454-18-000611 · edgar.xml · nonDerivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,086 Read SEC document |
| September 24, 2018 Filed Oct 2, 2018 22:58 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0000904454-18-000631 · edgar.xml · derivative · entry 3 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-01-05 F2 · shares: On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 30,000 shares. Read SEC document |
| April 06, 2018 Filed Jun 4, 2018 21:57 UTC | Verastem, Inc. VSTM · Entity 5242 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.97 | $0.00 |
DisclosureSEC source: 0001104659-18-038057 · a4.xml · derivative · entry 1 Paterson Dan · CIK 0001563202 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-01-05 F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.